FDG PET/CT should be part of primary staging in patients with T-cell lymphoma and may potentially change disease stage and patient management, according to a study published in the August issue of American Journal of Roentgenology.
The study retrospectively reviewed patients with T-cell lymphomas who underwent a PET/CT exam for initial disease staging or at disease relapse over a five-year period by correlation...
Intensive Chemotherapy May Be Harmful to Most Older Patients With Acute Myeloid Leukemia
WASHINGTON, July 28 /PRNewswire-USNewswire/ -- The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly...
Research Scientists at Texas A&M Identify Two Compounds Found in Stone Fruit That Kill Cancer Cells While Not Harming Normal Cells
REEDLEY, Calif.--(BUSINESS WIRE)--A recent study performed at Texas A&M University revealed that peaches and plums may present an even sweeter, juicier treat in their ability to fight breast cancer. According to research scientists Dr. Luis Cisneros-Zevallos and Dr. David Byrne...
By Crystal Phend, Senior Staff Writer, MedPage Today
Published: July 28, 2010
A risk score based on a number of uncommon genetic variants appears to predict risk of estrogen receptor-positive breast cancer but with questionable clinical utility, researchers said.
Women in the top 20% for the risk score had double the overall cumulative incidence of breast cancer to age 70 as did those in the bottom 20% at an estimated 8.8% versus 4.4%, according to Gillian K. Reeves,...
Researchers design a new version of cisplatin that spares the kidneys, letting doctors use higher doses.
Anne Trafton, MIT News Office
July 28, 2010
One of the first chemotherapy drugs given to patients diagnosed with cancer — especially lung, ovarian or breast cancer — is cisplatin, a platinum-containing compound that gums up tumor cells’ DNA. Cisplatin does a good job of killing those tumor cells, but it...
Blog Categories
Uncategorized
(5)
